Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lemaitre Vascular ( (LMAT) ) has issued an update.
LeMaitre Vascular, Inc. announced its intention to offer $150 million in Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers. The proceeds from this offering are expected to be used for working capital, and potentially for acquisitions or investments in complementary companies, product lines, or technologies, which could impact its market positioning and operations.
More about Lemaitre Vascular
LeMaitre Vascular, Inc. is a company that provides devices, implants, and services for the treatment of peripheral vascular disease, which affects over 200 million people globally. The company develops, manufactures, and markets disposable and implantable vascular devices, primarily catering to vascular surgeons.
YTD Price Performance: 78.82%
Average Trading Volume: 128,234
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.26B
See more data about LMAT stock on TipRanks’ Stock Analysis page.
Trending Articles
- Tesla Stock Upgraded to Buy by Mizuho with a New Street-High Price Target
- 3 Penny Stocks to Watch Now, 12/17/24
- TikTok Urges U.S. Supreme Court to Halt the Ban While Meta and Google Relish
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
